Fig. 2From: The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe diseaseFrequencies and percentages of patients with confirmed molecular diagnosis, negative diagnosis, or variants of unknown significance (VUS)Back to article page